ReutersAstraZeneca drug selumetinib fails in uveal melanoma trialReutersLONDON AstraZeneca's much anticipated cancer drug pipeline suffered a blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for uveal melanoma. The drugmaker said the setback would not affect other ...AstraZeneca Provides Update On Selumetinib In Uveal MelanomaCNNMoneyAstrazeneca Late Stage Selumetinib Combination Study Misses EndpointLondon South Eastall 5 news articles »
AstraZeneca drug selumetinib fails in uveal melanoma trial
Rating: 4.5
Diposkan Oleh: Unknown
